Organigram Revenue and Competitors

Moncton, NB CAN

Location

$528.3M

Total Funding

Cannabis

Industry

Estimated Revenue & Valuation

  • Organigram's estimated annual revenue is currently $90.2M per year.(i)
  • 0
  • Organigram's total funding is $528.3M.
  • Organigram's current valuation is $513.5M. (January 2022)

Employee Data

    00
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$90.2M0N/A$528.3MN/A
#2
$47.8M16125%N/AN/A
Add Company

Strong roots. At Organigram, it's a concept that matters. Organigram Inc. (TSX-V:OGI) is Atlantic Canada's original licensed producer of high-quality medical cannabis. Founded in 2013 and the 13th licensed applicant under the ACMPR (Access to Cannabis for Medical Purposes Regulations, formerly Marihuana for Medical Purposes Regulations), Organigram is committed to producing dried cannabis flower and extract oils of the highest standard and providing relief to patients across the country. For more information on Organigram's products, investor relations, or for information on becoming a patient, visit WWW.ORGANIGRAM.CA or call 1-855-961-9420.

keywords:N/A

$528.3M

Total Funding

N/A

Number of Employees

$90.2M

Revenue (est)

N/A

Employee Growth %

$513.5M

Valuation

N/A

Accelerator

Organigram News

2022-04-13 - Why Organigram Shares Popped Today

Canadian cannabis company Organigram Holdings ( OGI -3.80% ) reported its second-quarter fiscal 2022 earnings today, and investors liked...

2022-04-13 - Organigram Reports Second Quarter Fiscal 2022 Results

(together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the second quarter ended February...

2022-04-13 - Organigram Q2 Revenue Increases 5% Sequentially to $31.8 Million ...

Organigram Reports Second Quarter Fiscal 2022 Results. Achieves positive Adjusted EBITDA two quarters earlier than expected driven by record...

2019-03-20 - Organigram Announces Share Issuance

Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer

2019-03-10 - Is OrganiGram Holdings a Buy?

The stock in question is OrganiGram Holdings (NASDAQOTH:OGRMF). Had you bought OrganiGram in early 2016 and held on, you'd now be

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.3M10-94%N/A
#2
$2.8M130%N/A
#3
$1.2M14-18%N/A
#4
$1.3M16N/AN/A
#5
$1.2M1633%N/A